These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21518629)

  • 1. [A system review on the application of BED-capture enzyme immunoassay in detecting new HIV-1 infection].
    Tao J; Zhao J; Liu Y; Meng LZ; Yu SC; Jiang Y; Xiao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Feb; 32(2):177-81. PubMed ID: 21518629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.
    Laeyendecker O; Brookmeyer R; Oliver AE; Mullis CE; Eaton KP; Mueller AC; Jacobson LP; Margolick JB; Brown J; Rinaldo CR; Quinn TC; Eshleman SH;
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):816-22. PubMed ID: 22014036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.
    Xu J; Wang H; Jiang Y; Ding G; Jia M; Wang G; Chu J; Smith K; Sharp GB; Chen RY; Jin X; Dong R; Han X; Shang H; Wang N
    Int J Infect Dis; 2010 Jul; 14(7):e608-12. PubMed ID: 20102792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China.
    Jiang Y; Wang M; Ni M; Duan S; Wang Y; Feng J; Xiao Y; Dong Y; Wang D; Han M; Xiang L; Ma L; Zhou Q
    AIDS; 2007 Dec; 21 Suppl 8():S47-51. PubMed ID: 18172391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.
    McDougal JS; Parekh BS; Peterson ML; Branson BM; Dobbs T; Ackers M; Gurwith M
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):945-52. PubMed ID: 17067263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV incidence determination in the United States: a multiassay approach.
    Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
    J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the bed capture enzyme immunoassay useful for surveillance in concentrated epidemics? The case of female sex workers in Indonesia.
    Morineau G; Magnani R; Nurhayati A; Bollen L; Mustikawati DE
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):634-42. PubMed ID: 21706941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.
    Mullis CE; Munshaw S; Grabowski MK; Eshleman SH; Serwadda D; Brookmeyer R; Nalugoda F; Kigozi G; Kagaayi J; Tobian AA; Wawer M; Gray RH; Quinn TC; Laeyendecker O
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1146-50. PubMed ID: 23641870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of HIV incidence using BED capture enzyme immunoassay at a surveillance sentinel site of injection drug users in Guangxi].
    Wei X; Liu W; Li F; Wang X; Zheng WW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Dec; 43(12):1096-9. PubMed ID: 20193507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estimation on the HIV-1 incidence in Liangshan Yi Autonomous Prefecture, under BED-capture enzyme immunoassay, from 2011 to 2013].
    Zhao QG; Gong YH; Liao Q; Yu G; Wang K; Wang J; Yin BP; Yang SJ; Zhang JX; Liang PY; Wang QX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1105-7. PubMed ID: 27539341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay.
    Hayashida T; Gatanaga H; Tanuma J; Oka S
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):495-8. PubMed ID: 18327979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
    Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014.
    Hofmann A; Hauser A; Zimmermann R; Santos-Hövener C; Bätzing-Feigenbaum J; Wildner S; Kücherer C; Bannert N; Hamouda O; Bremer V; Bartmeyer B
    BMC Infect Dis; 2017 Jul; 17(1):484. PubMed ID: 28693564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
    Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of BED-CEIA to estimate the human immunodeficiency virus prevalence among injecting drug users in Chongqing municipality].
    Han M; Wang YL; Wang MJ; Zhou QH; Jiang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1077-80. PubMed ID: 18396659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.
    Longosz AF; Morrison CS; Chen PL; Arts E; Nankya I; Salata RA; Franco V; Quinn TC; Eshleman SH; Laeyendecker O
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):390-6. PubMed ID: 24583613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 incidence estimates among young Thai men using IgG-capture BED-enzyme immunoassay (BED-CEIA) during 2005-2006.
    Kana K; Tabprasit S; Chuenchitra T; Sirisopana N; Rangsin R
    J Med Assoc Thai; 2009 Feb; 92 Suppl 1():S112-6. PubMed ID: 21299183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.
    Wendel SK; Mullis CE; Eshleman SH; Blankson JN; Moore RD; Keruly JC; Brookmeyer R; Quinn TC; Laeyendecker O
    PLoS One; 2013; 8(2):e55525. PubMed ID: 23437058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.